FDA Approved: AVALIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

FDA approved a supplemental application for AVALIDE (irbesartan/hydrochlorothiazide) submitted by Sanofi-Aventis U.S. LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• AVALIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)

Snippet

SUPPL AP for AVALIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)